SCHEMBL30774177

SCHEMBL30774177

Cc1c(Cl)nc2ccccc2c1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.61
MAOB P27338 1/20 0.61
TDP1 Q9NUW8 2/20 0.50
GPR3 P46089 1/20 0.47
KDM4E B2RXH2 3/20 0.44
CYP1A2 P05177 2/20 0.44
PKM P14618 1/20 0.44
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
NUDT1 P36639 1/20 0.42
PDE10A Q9Y233 1/20 0.42
KMT2A Q03164 1/20 0.41
BACE1 P56817 1/20 0.41
NCF1 P14598 1/20 0.41
POLB P06746 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2712314 1.00 MAOA (0.61) MAOAMAOBTDP1GPR3KDM4E
SCHEMBL27943843 0.85 TDP1 (0.52) MAOAMAOBTDP1GPR3KDM4E
SCHEMBL5469806 0.83 MAOA (0.56) MAOAMAOBTDP1GPR3KDM4E
SCHEMBL2125436 0.83 MAOA (0.61) MAOAMAOBGPR3KDM4ECYP1A2
Ammonia Solution, Strong SCHEMBL27928855 0.82 MAOA (0.59) MAOAMAOBGPR3KDM4ECYP1A2
SCHEMBL6679033 0.80 MAOA (0.70) MAOAMAOBTDP1GPR3KDM4E
SCHEMBL9607475 0.80 MAOA (0.57) MAOAMAOBTDP1GPR3KDM4E
SCHEMBL12490195 0.80 MAOA (0.57) MAOAMAOBTDP1GPR3KDM4E
SCHEMBL2123575 0.79 PDE10A (0.58) MAOAMAOBTDP1KDM4EPKM
SCHEMBL29175203 0.78 MAOA (0.67) MAOAMAOBTDP1GPR3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240059703-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE AMGEN INC. 2024-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240059703-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE KRAS, HRAS, APC MAOA 4814/4885MAOB 4672/4885TDP1 4325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.